TEKLA CAPITAL MANAGEMENT LLC – BioMarin Pharmaceutical Inc. Transaction History
TEKLA CAPITAL MANAGEMENT LLC portfolio value:
$12.79M
portfolio value
TEKLA CAPITAL MANAGEMENT LLC quarter portfolio value change:
+2.29%
quarter
BioMarin Pharmaceutical Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +17.92% | 22.94K shares | 2.18M | $84.77 | 150.94K |
| Q2 2022 | share | 0.00% | 0 shares | 739K | $82.87 | 128.00K | |
| Q1 2022 | share | 0.00% | 0 shares | -1.44M | $77.1 | 128.00K | |
| Q4 2021 | share | 0.00% | 0 shares | 1.41M | $89.08 | 128.00K | |
| Q3 2021 | share | 0.00% | 0 shares | -788K | $77.29 | 128.00K | |
| Q2 2021 | share | 0.00% | 0 shares | 1.01M | $83.44 | 128.00K | |
| Q1 2021 | share | Decrease | -54.01% | -150.32K shares | -14.74M | $75.51 | 128.00K |
| Q4 2020 | share | Decrease | -14.58% | -47.49K shares | -382K | $87.69 | 278.33K |
| Q3 2020 | share | Increase | +32.79% | 80.46K shares | -5.47M | $76.08 | 325.82K |
| Q2 2020 | share | Decrease | -9.33% | -25.25K shares | 7.39M | $123.34 | 245.36K |
| Q1 2020 | share | Decrease | -2.15% | -5.94K shares | -516K | $84.5 | 270.61K |
| Q4 2019 | share | Increase | +12.53% | 30.79K shares | 6.81M | $84.55 | 276.56K |
| Q3 2019 | share | 0.00% | 0 shares | -4.48M | $67.4 | 245.76K | |
| Q2 2019 | share | Increase | +10.66% | 23.67K shares | 1.32M | $85.65 | 245.76K |
| Q1 2019 | share | Increase | +7.06% | 14.65K shares | 2.06M | $88.83 | 222.08K |
| Q4 2018 | share | Increase | +47.60% | 66.89K shares | 4.03M | $85.15 | 207.43K |
| Q3 2018 | share | 0.00% | 0 shares | 389K | $96.97 | 140.53K | |
| Q2 2018 | share | Decrease | -50.00% | -140.53K shares | -9.54M | $94.2 | 140.53K |
| Q1 2018 | share | Decrease | -42.61% | -208.66K shares | -20.88M | $81.07 | 281.07K |
| Q4 2017 | share | Decrease | -2.39% | -12K shares | -3.02M | $89.17 | 489.74K |
| Q3 2017 | share | 0.00% | 0 shares | 1.12M | $93.07 | 501.74K | |
| Q2 2017 | share | Decrease | -0.81% | -4.1K shares | 1.16M | $90.82 | 501.74K |
| Q1 2017 | share | Decrease | -11.67% | -66.8K shares | -3.03M | $87.78 | 505.84K |
| Q4 2016 | share | Decrease | -19.36% | -137.5K shares | -18.26M | $82.84 | 572.64K |
| Q3 2016 | share | Increase | +8.61% | 56.3K shares | 14.83M | $92.52 | 710.14K |
| Q3 2016 | call | Decrease | -100.00% | -57.7K shares | -4.48M | $92.52 | 0 |
| Q2 2016 | call | Increase | 0.00% | 57.7K shares | 4.48M | $77.8 | 57.7K |
| Q2 2016 | share | Increase | +9.68% | 57.7K shares | 1.69M | $77.8 | 653.84K |
| Q1 2016 | share | 0.00% | 0 shares | -13.28M | $82.48 | 596.14K |